secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CIK:        0001979414
Form:       8-K
Filed at:   2026-04-16T23:59:59+00:00
Accession:  0001829126-26-003566
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeOnc CEO buys ~$300k NTHI stock; FY2025 net loss $62M, mostly non-cash; clinical catalysts ahead
--------------------------------------------------------------------------------

- CEO Amir Heshmatpour purchased ~$300k of NTHI common stock in the past week, signaling confidence.
- FY2025 net loss ~$62M; ~$45.2M was non-cash stock comp ($35.6M) and one-time listing fees ($9.6M); normalized cash op ex ~$10.1M.
- NEO100 Phase 2a interim data readout expected ~August 2026 (within ~4 months).
- NEO212 Type B End-of-Phase FDA meeting within ~4 weeks to align on potential registrational Phase 2 study.
- Q1 2026 private placement raised ~$13M gross; proceeds used to repay convertible debt and obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1979414/000182912626003566/0001829126-26-003566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1979414/000182912626003566/neonctechnologies_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-003566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer